ORKAMBI
Jan 12, 2024
Is Bacteriophage a Potential Game-Changer in the Realm of Cystic Fibrosis Treatment?
Cystic Fibrosis impacts approximately 1 in every 3,500 births, with around 70,000 affected individuals globally, and 31,000 in the United States alone. Those with the condition experience the development of dense, adhesive mucus in their lungs, making them prone to infections. Over time, this leads to inflammation ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
